Literature DB >> 27560665

Nodal Disease Burden for Early-Stage Oral Cancer.

Kelly Yi Ping Liu1, J Scott Durham2, Jonn Wu3, Donald W Anderson2, Eitan Prisman2, Catherine F Poh4.   

Abstract

Importance: Nodal disease has a significant effect on survival of patients with oral squamous cell carcinoma (OSCC). The decision for elective neck dissection for clinically node-negative (cN0) disease remains elusive.
Objectives: To determine the efficacy of prophylactic neck treatment and to assess the value of commonly used clinicopathologic factors associated with nodal disease for early-stage OSCC. Design, Setting, and Participants: This retrospective study from a population-based cancer registry included patients diagnosed as having OSCC from January 11, 2001, to December 24, 2007, who were identified from the British Columbia Cancer Agency Registry. Comprehensive clinicopathologic data, treatment information, and time to outcome were collected. Five-year overall survival, disease-specific survival, and cumulative incidence of regional failure (RF) were analyzed. Receiver operating characteristic curve analysis with sensitivity and specificity was used to determine the association of these covariates with RF during follow-up. Data were analyzed from January 16 to June 30, 2015. Interventions: Follow-up of patients with cN0 OSCC with or without prophylactic neck treatment (elective neck dissection [END] and or radiotherapy). Main Outcomes and Measures: Patient demographic characteristics, clinicopathologic data, treatment data, and time from the initial surgery to last follow-up, the development of RF, or death due to oral cancer or other causes.
Results: Of the 469 patients with cN0 primary OSCC who underwent intent-to-cure surgery for the intraoral lesion, 447 received local excision (LE) for the primary tumor (256 men [57.3%] and 191 women [42.7%]; mean [SD] age, 63.3 [14.7] years). Patients who received prophylactic treatment of the neck (n = 125) compared with LE only (n = 322) had no survival advantage. The estimated 5-year overall and disease-specific survival rates were 61.9% (95% CI, 56.5%-67.8%) and 80.8% (95% CI, 76.1%-85.6%), respectively, for the LE-only group; 54.4% (95% CI, 45.9%-64.5%) and 73.1% (95% CI, 65%-82.3%), respectively, for the LE + END ± radiotherapy group; and 61.7% (95% CI, 52.3%-72.8%) and 80.3% (95% CI, 72%-89.4%), respectively, for the LE + END group. Among the patients with cN0 disease receiving LE only, 89 (27.6%; 95% CI, 23%-33%) developed RF at a median time of 10.8 months, and 71 of the RFs (79.8%) developed within 30 months. Tumor depth of invasion of at least 4 mm and tumor grade of 2 or 3 showed an association with RF but had poor sensitivity and specificity. Conclusions and Relevance: Commonly used pathologic factors to decide neck dissection for cN0 OSCC are not effective and can cause overtreatment or undertreatment. The need for identification of new objective approaches for risk assessment of RF is urgent.

Entities:  

Mesh:

Year:  2016        PMID: 27560665     DOI: 10.1001/jamaoto.2016.2241

Source DB:  PubMed          Journal:  JAMA Otolaryngol Head Neck Surg        ISSN: 2168-6181            Impact factor:   6.223


  7 in total

1.  Neck observation versus elective neck dissection in management of clinical T1/2N0 oral squamous cell carcinoma: a retrospective study of 232 patients.

Authors:  Xiangqi Liu; Xiaomei Lao; Lizhong Liang; Sien Zhang; Kan Li; Guiqing Liao; Yujie Liang
Journal:  Chin J Cancer Res       Date:  2017-06       Impact factor: 5.087

2.  Elective Neck Dissection Versus Observation in Early-Stage (cT1/T2N0) Oral Squamous Cell Carcinoma.

Authors:  Jin-Yong Liu; Chieh-Feng Chen; Chyi-Huey Bai
Journal:  Laryngoscope Investig Otolaryngol       Date:  2019-08-14

3.  Tumor microRNA profile and prognostic value for lymph node metastasis in oral squamous cell carcinoma patients.

Authors:  Kelly Yi Ping Liu; Sarah Yuqi Zhu; Denise Brooks; Reanne Bowlby; J Scott Durham; Yussanne Ma; Richard A Moore; Andrew J Mungall; Steven Jones; Catherine F Poh
Journal:  Oncotarget       Date:  2020-06-09

4.  The necessity of IIb dissection in T1-T2N0M0 oral squamous cell carcinoma: protocol for a randomized controlled trial.

Authors:  Lei Wang; Liang Wang; Xuefei Song; Chang Cui; Chunyue Ma; Bing Guo; Xingjun Qin
Journal:  Trials       Date:  2019-10-22       Impact factor: 2.279

5.  Quantitative nuclear phenotype signatures predict nodal disease in oral squamous cell carcinoma.

Authors:  Kelly Yi Ping Liu; Sarah Yuqi Zhu; Alan Harrison; Zhao Yang Chen; Martial Guillaud; Catherine F Poh
Journal:  PLoS One       Date:  2021-11-04       Impact factor: 3.240

6.  Metagenomic Analysis Reveals a Changing Microbiome Associated With the Depth of Invasion of Oral Squamous Cell Carcinoma.

Authors:  Yuan Liu; Zhengrui Li; Yanxu Qi; Xutao Wen; Ling Zhang
Journal:  Front Microbiol       Date:  2022-02-09       Impact factor: 5.640

7.  Depth of invasion in patients with early stage oral cancer staged by sentinel node biopsy.

Authors:  Inne J den Toom; Luuk M Janssen; Robert J J van Es; K Hakki Karagozoglu; Bart de Keizer; Stijn van Weert; Stefan M Willems; Elisabeth Bloemena; C René Leemans; Remco de Bree
Journal:  Head Neck       Date:  2019-01-28       Impact factor: 3.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.